Product News
University of Liverpool To Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical
The UK’s Medical Research Council is funding a 10-patient Phase I study to deliver rapid personalised treatment for lung cancer patients.
Product News
Therapeutic Potential of CD20 X CD3 Bispecific Antibodies
As of March 2024, the FDA has approved three CD20 × CD3 BsAbs: mosunetuzumab (Lunsumio) for relapsed or refractory follicular lymphoma (R/R FL), glofitamab (Columvi) for relapsed or refractory diffuse B cell lymphoma
Product News
Sino Biological Announces Services Partnership With Rapid Novor
Sino Biological and Rapid Novor partner to offer combined antibody development and sequencing services.
Product News
InSphero and PharmaNest Unveil a Promising Tool for MASH Drug Discovery
InSphero's Liver Disease team has published a groundbreaking peer-reviewed paper in Nature's Scientific Reports, challenging the limitations of in vitro models in MASH Drug Discovery.
Product News
ProBioGen Partners With MAPP BIOPHARMACEUTICAL, INC. for Groundbreaking Development of Afucosylated Antibody Against Marburg Virus Disease
ProBioGen, is pleased to announce the execution of services and license agreements with MAPP BIOPHARMACEUTICAL, INC. to develop a cell line for an afucosylated antibody targeting Marburg virus (MARV) infection.
Product News
Noramco Announces Strategic Alignment With Purisys and Halo Pharma, Launching the Noramco Group
The Noramco group addresses critical supply chain challenges, offering comprehensive active pharmaceutical ingredients (API) and drug product solutions.
Advertisement
